Cargando…

Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression

BACKGROUND: Ammonia is one of the chemical compounds that can cause acute and chronic effects to the workers. The purpose of this study is to determine the no-observed-adverse-effect level (NOAEL) ammonia in white mice. METHODS: This study applied a laboratory experimental with design post test-only...

Descripción completa

Detalles Bibliográficos
Autores principales: Tualeka, Abdul Rohim, Faradisha, Jihan, Maharja, Rizky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201189/
https://www.ncbi.nlm.nih.gov/pubmed/30369842
http://dx.doi.org/10.1177/1559325818807790
_version_ 1783365460172996608
author Tualeka, Abdul Rohim
Faradisha, Jihan
Maharja, Rizky
author_facet Tualeka, Abdul Rohim
Faradisha, Jihan
Maharja, Rizky
author_sort Tualeka, Abdul Rohim
collection PubMed
description BACKGROUND: Ammonia is one of the chemical compounds that can cause acute and chronic effects to the workers. The purpose of this study is to determine the no-observed-adverse-effect level (NOAEL) ammonia in white mice. METHODS: This study applied a laboratory experimental with design post test-only control group design using white mice as an object. The process of finding the safe limit began by determining the highest dose and the lowest dose of ammonia without effect in white mice. RESULTS: The latest research showed that the highest dose without effect is 0.0456 mg/kg and the lowest dose without effect is 0.0046 mg/kg. After determining the highest and the lowest dose of ammonia, the researcher started to determine the middle dose. The middle dose is the dose between the highest and the lowest doses with the multiplication of 1.5 starting from the lowest dose (there are 5 middle-dose variations from 5 middle concentration variations), consisting of 0.0872, 0.1309, 0.1963, 0.2944, and 0.4416 mg/m(3). CONCLUSION: From the result of the middle dose and the lowest dose without effect, it is found the value of the highest NH(3) dose without effect, which showed the highest Index Remmele Scale (IRS) CD4 before the reduction of IRS. The study concludes that the NOAEL of ammonia contained in white mice is 0.0103 mg/kg body weight of the mice.
format Online
Article
Text
id pubmed-6201189
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-62011892018-10-26 Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression Tualeka, Abdul Rohim Faradisha, Jihan Maharja, Rizky Dose Response Original Article BACKGROUND: Ammonia is one of the chemical compounds that can cause acute and chronic effects to the workers. The purpose of this study is to determine the no-observed-adverse-effect level (NOAEL) ammonia in white mice. METHODS: This study applied a laboratory experimental with design post test-only control group design using white mice as an object. The process of finding the safe limit began by determining the highest dose and the lowest dose of ammonia without effect in white mice. RESULTS: The latest research showed that the highest dose without effect is 0.0456 mg/kg and the lowest dose without effect is 0.0046 mg/kg. After determining the highest and the lowest dose of ammonia, the researcher started to determine the middle dose. The middle dose is the dose between the highest and the lowest doses with the multiplication of 1.5 starting from the lowest dose (there are 5 middle-dose variations from 5 middle concentration variations), consisting of 0.0872, 0.1309, 0.1963, 0.2944, and 0.4416 mg/m(3). CONCLUSION: From the result of the middle dose and the lowest dose without effect, it is found the value of the highest NH(3) dose without effect, which showed the highest Index Remmele Scale (IRS) CD4 before the reduction of IRS. The study concludes that the NOAEL of ammonia contained in white mice is 0.0103 mg/kg body weight of the mice. SAGE Publications 2018-10-22 /pmc/articles/PMC6201189/ /pubmed/30369842 http://dx.doi.org/10.1177/1559325818807790 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Tualeka, Abdul Rohim
Faradisha, Jihan
Maharja, Rizky
Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression
title Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression
title_full Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression
title_fullStr Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression
title_full_unstemmed Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression
title_short Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression
title_sort determination of no-observed-adverse-effect level ammonia in white mice through cd4 expression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201189/
https://www.ncbi.nlm.nih.gov/pubmed/30369842
http://dx.doi.org/10.1177/1559325818807790
work_keys_str_mv AT tualekaabdulrohim determinationofnoobservedadverseeffectlevelammoniainwhitemicethroughcd4expression
AT faradishajihan determinationofnoobservedadverseeffectlevelammoniainwhitemicethroughcd4expression
AT maharjarizky determinationofnoobservedadverseeffectlevelammoniainwhitemicethroughcd4expression